Sequoia Financial Advisors’s Vivos Therapeutics VVOS Stock Holding History

Sequoia Financial Advisors’s Portfolio VVOS Stock Details VVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.9K	Hold	24,000	–	–	﹤0.01%	2154
2026 Q1	$28.3K	Buy	+24,000	New	+$38.5K	﹤0.01%	1905

Other funds holding VVOS

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

CWM

Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return

Kozak & Associates Highlands Ranch, Colorado $576M AUM 23.37% 1-Year Est. Return

Sequoia Financial Advisors's VVOS Position: Q2 2026 in Review

Sequoia Financial Advisors held its Vivos Therapeutics (VVOS) position steady in Q2 2026 at 24,000 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2154.

Sequoia Financial Advisors first reported a position in VVOS in Q1 2026 and has held it in 2 quarters since. The position peaked at $28.3K in Q1 2026. 4 funds tracked by Wall St. Rank hold VVOS as of Q2 2026.

Sequoia Financial Advisors held 24,000 shares of Vivos Therapeutics worth $10.9K as of Q2 2026.
Sequoia Financial Advisors left its Vivos Therapeutics share count unchanged in Q2 2026.
Vivos Therapeutics made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #2154 holding.
Sequoia Financial Advisors first reported a position in Vivos Therapeutics in Q1 2026 and has held it in 2 quarters since.
Sequoia Financial Advisors's Vivos Therapeutics position peaked at $28.3K in Q1 2026.
4 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.